Pyrimidine ribonucleotide metabolic process

pathway activity — cross-omics
GO:0009218Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Pyrimidine ribonucleotide metabolic process pathway is significantly associated with the protein abundance of multiple proteins, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are BRD9_S566, ANLN_S485, and DNAJA4_S336, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Pyrimidine ribonucleotide metabolic process activity versus BRD9_S566 in BRCA (Pearson r = -0.23).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCABRD9_S566 →-0.705-0.026<.001.00234
LUADANLN_S485 →+0.812+0.036.008.00534
PDACDNAJA4_S336 →+0.563+0.038<.001<.00134
PDACKIFBP →+0.149+0.021<.001.00134
GBMWDR54 →+0.296+0.036<.001<.00134
GBMZNF318_T161 →-0.366-0.046.002.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0009218 vs BRD9_S566 — BRCA

Per-sample scatter of Pyrimidine ribonucleotide metabolic process activity vs BRD9_S566 in BRCA.

Explore this scatter interactively →

Exploration